Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center, shared a post on LinkedIn:
“What is the EQUAL study?
Early detection of EGFR lung cancer in family members of patients with EGFR + NSCLC by utilizing a novel blood assay. (With mobile phlebotomy – we come to you, NE only).
Email us at [email protected] if interested in participating.”